Annals of internal medicine

• Latest
• Best
• Search…

• Ann. Intern. Med. · Jan 2021

  Comment

  Efficacy and safety of dapagliflozin were similar in patients with type 2 DM and atherosclerotic CVD, regardless of PAD.

  Bonaca MP, Wiviott SD, Zelniker TA, et al. Dapagliflozin and cardiac, kidney, and limb outcomes in patients with and without peripheral artery disease in DECLARE-TIMI 58. Circulation. 2020;142:734-47. 32795086.

  expand abstract… or not…

• Ann. Intern. Med. · Jan 2021

  Comment

  In older patients with AF, low-dose edoxaban reduced stroke or systemic embolism without increasing major bleeding.

  Okumura K, Akao M, Yoshida T, et al. Low-dose edoxaban in very elderly patients with atrial fibrillation. N Engl J Med. 2020;383:1735-45. 32865374.

  read more… or not…

• Ann. Intern. Med. · Jan 2021

  Comment

  In patients with early AF and CV conditions, early rhythm-control therapy vs. usual care reduced CV events at 5 years.

  Kirchhof P, Camm AJ, Goette A, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020;383:1305-16. 32865375.

  read more… or not…

• Ann. Intern. Med. · Jan 2021

  Annals for Hospitalists Inpatient Notes - Corticosteroids and COVID-19-Calming the Storm?

  no abstract available

  read more… mark as read…

• Ann. Intern. Med. · Jan 2021

  Editorial Comment

  Maxims for a Pandemic: Time, Distance, and Data.

  no abstract available

  read more… or not…